Executive Director and Chief Executive Officer

Group CFO and Executive Director

AstraZeneca vows $15B China investment to boost cell therapy and radioconjugate capabilities

FDA knocks back AstraZeneca's self-injected lupus drug

AstraZeneca signs $18.5b deal for next-gen slimming drugs

FDA issues CRL on AstraZeneca’s Saphnelo BLA

0.5714285969734192

Director Cell Therapy CMC Program Lead - Late Stage

AstraZeneca's Oncology R&D division is dedicated to exploring and innovating to treat complex diseases. The Cell Therapy CMC Program Lead Director will lead cross-functional teams in developing cell therapy products, overseeing project timelines, budgets, and regulatory submissions while fostering collaboration across various departments.

Global Chief Technology Officer

Chief Financial Officer

AI-Enhanced SAP Modernization: Kyndryl Delivers Speed and Agility for Enterprises

Kyndryl Partners with Hertz on Technology Transformation

Kyndryl Unveils New Approach to Driving SAP Modernization Powered by Agentic AI

Oracle, Partners Pave Way for AI Breakthroughs in Brazil

Director, AWS Technology & Innovation Leader

Kyndryl is a technology services company that designs, builds, and manages critical technology systems. The Director, AWS Technology & Innovation Leader will drive cloud transformation initiatives, lead technical strategy, and oversee solution design and innovation in AWS technologies for enterprise clients.

AstraZeneca is a leading pharmaceutical company focused on innovative treatments in oncology. The Cell Therapy CMC Program Lead Director is responsible for leading cross-functional teams in the development and commercialization of cell therapy products, ensuring alignment with business objectives and regulatory requirements.

Chief Executive Officer

Landmark Bio and Mass General Brigham partner to accelerate translational CGT therapies

Artis BioSolutions Emerges from Stealth with Acquisition

Gene therapy CDMO Artis BioSolutions launches with acquisition of Landmark Bio

Landmark Bio Acquired by Artis BioSolutions

0.8571428656578064

Director, CMC Technology & Innovation Program Lead

Landmark Bio is dedicated to translating cutting-edge research into life-changing therapies. They are seeking an experienced and visionary Director, CMC Technology & Innovation Program Lead to drive the development of next-generation biomanufacturing platforms, focusing on continuous and integrated bioprocessing while collaborating with clients and leading internal innovation initiatives.

SVP, Strategy and Business Development

Director, IRT and Technology Lead

Alexion Pharmaceuticals discloses C1S inhibitors

AstraZeneca Unit Gets Partial Win in Soliris Drug Monopoly Case

Complement C5 Inhibitors & C5 Receptor Antagonists Pipeline and Competitive Intelligence Report 2025 - ResearchAndMarkets.com

AstraZeneca Secures FDA Approval for Koselugo to Treat Adults with NF1 Plexiform Neurofibromas Following Positive Phase III KOMET Results

Alexion Pharmaceuticals, Inc. is committed to exploring and innovating within the field of Oncology R&D. The Cell Therapy CMC Program Lead Director is responsible for leading cross-functional matrix teams in the development and execution of CMC programs for cell therapy products, ensuring alignment with business objectives and regulatory requirements.

Vice President & Chief Communications and Marketing Officer

Deputy CIO

Federal court rules IU’s August 2024 expressive action policy was unconstitutional

Researchers develop innovative product that could have major impact on women's health: 'The potential to make a serious difference'

23andMe Research Institute Appoints Privacy Advisory Board

Fired Indiana University student newspaper adviser claims free speech violation in federal lawsuit

0.7142857313156128

Director of Technology Development

Indiana University is a leading research institution committed to fostering innovation and commercialization. The Director of Technology Development will oversee technology transfer processes, manage faculty engagement, and support the commercialization of intellectual property to enhance the university's research impact.

Director of Technology Development (Innovation and Commercial Leader)